To assess whether EZH2 is implicated in AKI, we first examined the effects of 3-DZNep, an inhibitor of S-adenosylmethionine-dependent methyltransferase that targets the degradation of EZH227, on renal function in murine models of IR or FA. The gene discussed is EZH2; the disease is acute kidney injury.